Correlation Between Iproeb SA and Farmaceutica

Can any of the company-specific risk be diversified away by investing in both Iproeb SA and Farmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iproeb SA and Farmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Iproeb SA and Farmaceutica R, you can compare the effects of market volatilities on Iproeb SA and Farmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iproeb SA with a short position of Farmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iproeb SA and Farmaceutica.

Diversification Opportunities for Iproeb SA and Farmaceutica

0.83

Correlation Coefficient

Iproeb SA  Farmaceutica

Very poor diversification

The 3 months correlation between Iproeb and Farmaceutica is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Iproeb SA and Farmaceutica R in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Farmaceutica R and Iproeb SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iproeb SA are associated (or correlated) with Farmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Farmaceutica R has no effect on the direction of Iproeb SA i.e., Iproeb SA and Farmaceutica go up and down completely randomly.

Pair Corralation between Iproeb SA and Farmaceutica

Assuming the 90 days trading horizon Iproeb SA is expected to under-perform the Farmaceutica. In addition to that, Iproeb SA is 1.31 times more volatile than Farmaceutica R. It trades about -0.05 of its total potential returns per unit of risk. Farmaceutica R is currently generating about -0.04 per unit of volatility. If you would invest  71.00  in Farmaceutica R on September 27, 2024 and sell it today you would lose (7.00) from holding Farmaceutica R or give up 9.86% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Iproeb SA  vs.  Farmaceutica R

Iproeb SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Iproeb SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Farmaceutica R

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Farmaceutica R has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Iproeb SA and Farmaceutica

The main advantage of trading using opposite Iproeb SA and Farmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iproeb SA position performs unexpectedly, Farmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Farmaceutica will offset losses from the drop in Farmaceutica's long position.

The idea behind Iproeb SA and Farmaceutica R pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.